Oceania Healthcare Limited (NZE:OCA)
New Zealand · Delayed Price · Currency is NZD 0.8500
0.00 (0.00%)
At close: Jan 30, 2026
Oceania Healthcare Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 259.6 | 260.57 | 265.46 | 247.18 | 231.14 | 210.5 |
Other Revenue | - | - | - | - | - | 2.45 |
| 259.6 | 260.57 | 265.46 | 247.18 | 231.14 | 212.95 | |
Revenue Growth (YoY) | -2.57% | -1.84% | 7.40% | 6.94% | 8.54% | 8.52% |
Cost of Revenue | 185.11 | 185.19 | 185.55 | 164.48 | 156.45 | 138.87 |
Gross Profit | 74.49 | 75.38 | 79.91 | 82.7 | 74.69 | 74.08 |
Selling, General & Admin | - | - | - | 0.16 | 2.5 | 4.94 |
Other Operating Expenses | 72.29 | 74.59 | 70.46 | 66.78 | 59.99 | 56.91 |
Operating Expenses | 96.01 | 96.74 | 89.45 | 84.86 | 81.11 | 78.09 |
Operating Income | -21.52 | -21.36 | -9.54 | -2.17 | -6.42 | -4.01 |
Interest Expense | -22.96 | -20.83 | -10.9 | -9.12 | -5.76 | -4.27 |
Interest & Investment Income | 3.11 | 3.11 | 4.54 | 1.76 | 0.08 | 0.03 |
Other Non Operating Income (Expenses) | -0.39 | 1.82 | -3.59 | -2.86 | -0.19 | -3.88 |
EBT Excluding Unusual Items | -41.75 | -37.25 | -19.48 | -12.38 | -12.29 | -12.14 |
Impairment of Goodwill | -0.09 | -0.2 | -0.56 | -2.35 | -0.41 | -1.46 |
Gain (Loss) on Sale of Assets | -0.84 | -0.85 | -5.77 | 2.63 | -0.03 | 0.1 |
Asset Writedown | 89.07 | 64.16 | 51.51 | 13.48 | 58.62 | 103.84 |
Other Unusual Items | - | - | - | -1.4 | 10.36 | - |
Pretax Income | 46.39 | 25.85 | 28.39 | 12 | 56.25 | 90.34 |
Income Tax Expense | -6.04 | -4.56 | -3.08 | -3.45 | -4.88 | -12.48 |
Net Income | 52.42 | 30.42 | 31.47 | 15.45 | 61.13 | 102.82 |
Net Income to Common | 52.42 | 30.42 | 31.47 | 15.45 | 61.13 | 102.82 |
Net Income Growth | - | -3.36% | 103.74% | -74.73% | -40.54% | - |
Shares Outstanding (Basic) | 724 | 724 | 723 | 715 | 705 | 622 |
Shares Outstanding (Diluted) | 724 | 724 | 724 | 716 | 705 | 622 |
Shares Change (YoY) | 0.01% | 0.08% | 1.12% | 1.46% | 13.49% | 1.77% |
EPS (Basic) | 0.07 | 0.04 | 0.04 | 0.02 | 0.09 | 0.17 |
EPS (Diluted) | 0.07 | 0.04 | 0.04 | 0.02 | 0.09 | 0.17 |
EPS Growth | - | -2.33% | 99.12% | -75.08% | -47.61% | - |
Free Cash Flow | 99.3 | 70.04 | 50.17 | 14.1 | 49.23 | 71.72 |
Free Cash Flow Per Share | 0.14 | 0.10 | 0.07 | 0.02 | 0.07 | 0.12 |
Dividend Per Share | - | - | - | 0.032 | 0.044 | 0.041 |
Dividend Growth | - | - | - | -27.27% | 7.84% | 16.57% |
Gross Margin | 28.69% | 28.93% | 30.10% | 33.46% | 32.31% | 34.79% |
Operating Margin | -8.29% | -8.20% | -3.59% | -0.88% | -2.78% | -1.88% |
Profit Margin | 20.19% | 11.67% | 11.86% | 6.25% | 26.45% | 48.28% |
Free Cash Flow Margin | 38.25% | 26.88% | 18.90% | 5.71% | 21.30% | 33.68% |
EBITDA | -1.46 | -2.34 | 6.78 | 13.02 | 9.02 | 9.5 |
EBITDA Margin | -0.56% | -0.90% | 2.55% | 5.27% | 3.90% | 4.46% |
D&A For EBITDA | 20.06 | 19.02 | 16.32 | 15.19 | 15.44 | 13.51 |
EBIT | -21.52 | -21.36 | -9.54 | -2.17 | -6.42 | -4.01 |
EBIT Margin | -8.29% | -8.20% | -3.59% | -0.88% | -2.78% | -1.88% |
Revenue as Reported | 349.26 | 355.68 | 335.41 | 285.97 | 308.48 | 311.7 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.